• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry.

Share:

July 17, 2023

Verily and L’Oreal have launched a multi-year study called My Skin & Hair Journey to advance precision skin and hair health. The study aims to gather knowledge about perceptions and experiences of skin and hair health, including lifestyle, environment, wellness, and personal beauty routines. Women aged 18-70 from diverse backgrounds are invited to share their skin and hair health journeys through self-reported data and surveys. Insights from the study will help L’Oreal develop innovative, personalized beauty products to support consumers’ skin and hair goals.

What You Should Know:

  • Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies’ multi-year partnership and research collaboration.
  • The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle, environment, wellness, and personal beauty routines.

My Skin & Hair Journey Registry

The My Skin & Hair Journey registry includes self-identifying women aged 18-70 from various ethnicities, social backgrounds and with diverse skin and hair attributes are invited to take part by privately sharing their unique skin and hair health journeys through self-reported data and surveys. A subgroup of participants will also be invited to further testing to uncover biomarkers — unique biological signatures – that can lead to early detection or prevention of skin disorders, before they take hold. L’Oréal will leverage insights generated from the registry to develop innovative, precision beauty offerings to support the skin and hair goals of all consumers.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Skin health cohorts play a crucial role in unraveling the intricate connection between a wide range of biomarkers and skin health outcomes,” said Guive Balooch, L’Oréal’s Global Managing Director of Augmented Beauty and Open Innovation. “Engaging regularly over time with the study participants allows us to observe changes, pinpoint risk factors, and develop personalized skincare recommendations that enhance overall skin health and well-being. This comprehensive understanding contributes to the development of more precise and inclusive skincare approaches that cater to the diverse needs of individuals worldwide.”

The My Skin & Hair Journey longitudinal registry for skin and hair health is now enrolling participants in the United States, with the intention to expand internationally. For those interested in joining, more information can be found here.

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • DiNAQOR Acquires EHT Technologies GmbH to Advance Engineered Heart Tissue R&D CapabilitiesDiNAQOR Acquires EHT Technologies GmbH to Advance Engineered Heart Tissue R&D Capabilities
  • Vander-Bend Completes Strategic Acquisition Of TMK Manufacturing, A Leading Specialty Prototyper And Manufacturer Serving Medical Technology OEMsVander-Bend Completes Strategic Acquisition Of TMK Manufacturing, A Leading Specialty Prototyper And Manufacturer Serving Medical Technology OEMs
  • ObvioHealth Launches Digital Therapeutics API for Clinical TrialsObvioHealth Launches Digital Therapeutics API for Clinical Trials
  • SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene TherapiesSAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies
  • Apple, Google Partner On COVID-19 Contact Tracing Tech: 5 Things To KnowApple, Google Partner On COVID-19 Contact Tracing Tech: 5 Things To Know
  • Sobi Expands Hematology Portfolio with $1.7B Buy of CTISobi Expands Hematology Portfolio with $1.7B Buy of CTI
  • BIO-TECHNE TO ACQUIRE NAMOCELLBIO-TECHNE TO ACQUIRE NAMOCELL
  • Elvie Launches New Smart Breast Pump in the US Covered By InsuranceElvie Launches New Smart Breast Pump in the US Covered By Insurance

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications